{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:34:31Z","timestamp":1790883271040,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004046","name":"Karen Elise Jensen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ejvs.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T07:58:19Z","timestamp":1707379099000},"page":"948-957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease: A Danish Population Based Cohort Study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4693-8179","authenticated-orcid":false,"given":"Maja","family":"Thaarup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4166-9988","authenticated-orcid":false,"given":"Sara","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2922-6970","authenticated-orcid":false,"given":"Peter Br\u00f8nnum","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5364-0701","authenticated-orcid":false,"given":"Chalotte Winther","family":"Nicolajsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaj","family":"Eldrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8434-7244","authenticated-orcid":false,"given":"Christian Nikolaj","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian-Alexander","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-3069","authenticated-orcid":false,"given":"Anette Arbjerg","family":"H\u00f8jen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2830-4968","authenticated-orcid":false,"given":"Mette","family":"S\u00f8gaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2024.02.002_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Abbafati","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2024.02.002_bib2","doi-asserted-by":"crossref","unstructured":"Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health 2019;7:e1020\u201330.","DOI":"10.1016\/S2214-109X(19)30255-4"},{"key":"10.1016\/j.ejvs.2024.02.002_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejvs.2020.11.013","article-title":"Editor\u2019s Choice \u2013 The GermanVasc score: a pragmatic risk score predicts five year amputation free survival in patients with peripheral arterial occlusive disease","volume":"61","author":"Kreutzburg","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.002_bib4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacc.2019.11.050","article-title":"Long-term outcomes and associations with major adverse limb events after peripheral artery revascularization","volume":"75","author":"Hess","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2024.02.002_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2024.02.002_bib6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ejvs.2024.02.002_bib7","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.02.002_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/ATVBAHA.119.312142","article-title":"Evidence-based medical management of peripheral artery disease","volume":"40","author":"Bevan","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejvs.2024.02.002_bib9","doi-asserted-by":"crossref","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task force on clinical practice guidelines. Circulation 2017;135:e686-e725.","DOI":"10.1161\/CIR.0000000000000501"},{"key":"10.1016\/j.ejvs.2024.02.002_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"Editor\u2019s Choice \u2013 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.002_bib11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ejvs.2023.03.042","article-title":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on antithrombotic therapy for vascular diseases","volume":"65","author":"Twine","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.002_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.002_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination study, 1999 to 2004","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.02.002_bib14","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2017.02.064","article-title":"Underuse of prevention and lifestyle counseling in patients with peripheral artery disease","volume":"69","author":"Berger","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2024.02.002_bib15","first-page":"1","article-title":"Adherence to guideline-recommended therapy\u2014including supervised exercise therapy referral\u2014across peripheral artery disease specialty clinics: insights from the international PORTRAIT registry","volume":"9","author":"Saxon","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2024.02.002_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.amjmed.2013.01.033","article-title":"Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis","volume":"126","author":"Kumbhani","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.ejvs.2024.02.002_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/VHRM.S76651","article-title":"Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease","volume":"11","author":"Chen","year":"2015","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.ejvs.2024.02.002_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejvs.2020.05.001","article-title":"Editor\u2019s Choice - optimal pharmacological treatment of symptomatic peripheral arterial occlusive disease and evidence of female patient disadvantage: an analysis of health\u00a0insurance claims data","volume":"60","author":"Peters","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.002_bib19","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.112.108787","article-title":"Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains","volume":"126","author":"Subherwal","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.02.002_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020333","article-title":"Trends in use of cardioprotective medication in peripheral artery disease: a nationwide study","volume":"10","author":"Kamil","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2024.02.002_bib21","article-title":"Peripheral artery disease in Germany (2009\u20132018): prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy \u2013 a population-based study","volume":"5","author":"Rammos","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ejvs.2024.02.002_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018184","article-title":"Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in the Health Improvement Network in the UK","volume":"8","author":"Cea-Soriano","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejvs.2024.02.002_bib23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/bjs\/znac241","article-title":"Effects of a person-centred, nurse-led follow-up programme on adherence to prescribed medication among patients surgically treated for intermittent claudication: randomized clinical trial","volume":"109","author":"Haile","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejvs.2024.02.002_bib24","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.02.002_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Heal"},{"key":"10.1016\/j.ejvs.2024.02.002_bib26","first-page":"1","article-title":"Adherence to antiplatelet medications among persistent and non-persistent older patients with peripheral arterial disease","volume":"9","author":"Wawruch","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejvs.2024.02.002_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.687549","article-title":"Non-persistence with antiplatelet medications among older patients with peripheral arterial disease","volume":"12","author":"Wawruch","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejvs.2024.02.002_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejvs.2018.09.023","article-title":"Adherence to prescribed drugs among 65\u201374 year old men diagnosed with abdominal aortic aneurysm or peripheral arterial disease in a screening trial: a VIVA substudy","volume":"57","author":"Qvist","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.002_bib29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/2047487313519344","article-title":"Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study","volume":"22","author":"Subherwal","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ejvs.2024.02.002_bib30","first-page":"142","article-title":"Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: trends between 1997 and 2016","volume":"9","author":"Kamil","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2024.02.002_bib31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ejvs.2024.02.002_bib32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ejvs.2024.02.002_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.ejvs.2024.02.002_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1403494810394715","article-title":"Danish education registers","volume":"39","author":"Jensen","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.ejvs.2024.02.002_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1403494811405098","article-title":"Danish registers on personal income and transfer payments","volume":"39","author":"Baadsgaard","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.ejvs.2024.02.002_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1403494811399956","article-title":"Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving","volume":"39","author":"Thygesen","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.ejvs.2024.02.002_bib37","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1185\/03007990903126833","article-title":"Good and poor adherence: optimal cut-point for adherence measures using administrative claims data","volume":"25","author":"Karve","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ejvs.2024.02.002_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejvs.2007.08.008","article-title":"Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction","volume":"35","author":"Gasse","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.002_bib39","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jacc.2019.11.053","article-title":"In-hospital outcomes and discharge medication use among patients with critical limb ischemia versus claudication","volume":"75","author":"Rymer","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2024.02.002_bib40","article-title":"Underuse of cardiovascular medications in individuals with known lower extremity peripheral artery disease","volume":"9","author":"Hua","year":"2020","journal-title":"HCHS\/SOL. J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2024.02.002_bib41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.avsg.2017.06.152","article-title":"Surgical intervention for peripheral artery disease does not improve patient compliance with recommended medical therapy","volume":"46","author":"Halle","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.002_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCULATIONAHA.120.047994","article-title":"Temporal changes in secondary prevention and cardiovascular outcomes after revascularization for peripheral arterial disease in Denmark: a nationwide cohort study","volume":"143","author":"S\u00f8gaard","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.02.002_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjqs-2023-016520","article-title":"Quality of care for secondary cardiovascular disease prevention in 2009\u20132017: population-wide cohort study of antiplatelet therapy use in Scotland","author":"Thalmann","year":"2023","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.ejvs.2024.02.002_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-016-0283-6","article-title":"Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction","volume":"16","author":"Halvorsen","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ejvs.2024.02.002_bib45","first-page":"247","article-title":"Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain","volume":"19","author":"Sanf\u00e9lix-Gimeno","year":"2013","journal-title":"J\u00a0Manag Care Pharm"},{"key":"10.1016\/j.ejvs.2024.02.002_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6585040","article-title":"Adherence to antiplatelet therapy after coronary intervention among patients with myocardial infarction attending Vietnam National Heart Institute","volume":"2019","author":"Luu","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ejvs.2024.02.002_bib47","article-title":"Persistence and adherence to cardiovascular medicines in Australia","volume":"12","author":"Costa","year":"2023","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2024.02.002_bib48","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1001\/archinte.163.18.2157","article-title":"Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease","volume":"163","author":"McDermott","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejvs.2024.02.002_bib49","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/14017431.2019.1645350","article-title":"Peripheral artery disease patients are poorly aware of their disease","volume":"53","author":"Builyte","year":"2019","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.ejvs.2024.02.002_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.avsg.2018.11.034","article-title":"Perceptions of Canadian Vascular surgeons toward pharmacologic risk reduction in patients with peripheral artery disease: 2018 update","volume":"58","author":"Li","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.002_bib51","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1525-1497.2002.20307.x","article-title":"Atherosclerotic risk factor reduction in peripheral arterial disease","volume":"17","author":"McDermott","year":"2002","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.ejvs.2024.02.002_bib52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejvs.2019.09.006","article-title":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2020 clinical practice guidelines on the management of acute limb ischaemia","volume":"59","author":"Bj\u00f6rck","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.002_bib53","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejvs.2016.12.031","article-title":"Validity of peripheral arterial disease diagnoses in the Danish National Patient Registry","volume":"53","author":"Lasota","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.002_bib54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/CLEP.S59156","article-title":"Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999\u20132012","volume":"6","author":"Schmidt","year":"2014","journal-title":"Clin Epidemiol"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588424001618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588424001618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T04:02:05Z","timestamp":1717819325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588424001618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1078588424001618"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2024.02.002","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease: A Danish Population Based Cohort Study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}